JTT-501, a new oral hypoglycemic agent, reverses hypertriglyceridemia in Zucker fatty and ventromedial hypothalamus-lesioned obese rats.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples